Estrogen receptor-α hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome

Molecular Endocrinology

Volumn 22, Issue 7, 2008, Pages 1535-1551

  Berry, Nicholas B ^a   Fan, Meiyun ^b   Nephew, Kenneth P ^a,c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Indiana University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAG 1 PROTEIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; HEAT SHOCK COGNATE PROTEIN 70; LYSINE; PROTEASOME; UBIQUITIN PROTEIN LIGASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HELA CELL; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; UBIQUITINATION;

ALANINE; CELL LINE; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; HELA CELLS; HUMANS; LYSINE; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TIME FACTORS; UBIQUITIN;

EID: 46349108800     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0449     Document Type: Article

References (66)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
2. Key TJ, Verkasalo PK, Banks E 2001 Epidemiology of breast cancer. Lancet Oncol 2:133-140
3. Ciocca DR, Fanelli MA 1997 Estrogen receptors and cell proliferation in breast cancer. Trends Endocrinol Metab 8:313-321
4. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ 1992 The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 6:157-167
5. Fan M, Nakshatri H, Nephew KP 2004 Inhibiting proteasomal proteolysis sustains estrogen receptor-α activation. Mol Endocrinol 18:2603-2615
6. Sommer S, Fuqua SA 2001 Estrogen receptor and breast cancer. Semin Cancer Biol 11:339-352
7. Reid G, Denger S, Kos M, Gannon F 2002 Human estrogen receptor-α: regulation by synthesis, modification and degradation. Cell Mol Life Sci 59:821-831
8. Alarid ET, Bakopoulos N, Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534
9. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862
10. El Khissiin A, Leclercq G 1999 Implication of proteasome in estrogen receptor degradation. FEBS Lett 448:160-166
11. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948
12. Wijayaratne AL, McDonnell DP 2001 The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684-35692
13. Nonclercq D, Journe F, Body JJ, Leclercq G, Laurent G 2004 Ligand-independent and agonist-mediated degradation of estrogen receptor-α in breast carcinoma cells: evidence for distinct degradative pathways. Mol Cell Endocrinol 227:53-65
14. Laios I, Journe F, Nonclercq D, Vidal DS, Toillon RA, Laurent G, Leclercq G 2005 Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol 94:347-359
15. Devin-Leclerc J, Meng X, Delahaye F, Leclerc P, Baulieu EE, Catelli MG 1998 Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. Mol Endocrinol 12:842-854
16. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA 2001 FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent. Nat Cell Biol 3:15-23
17. Marsaud V, Gougelet A, Maillard S, Renoir JM 2003 Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Mol Endocrinol 17:2013-2027
18. Tateishi Y, Kawabe Y, Chiba T, Murata S, Ichikawa K, Murayama A, Tanaka K, Baba T, Kato S, Yanagisawa J 2004 Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. EMBO J 23:4813-4823
19. Fan M, Park A, Nephew KP 2005 CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α. Mol Endocrinol 19:2901-2914
20. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707
21. Pratt WB 1997 The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37:297-326
22. Bagatell R, Khan O, Paine-Murrieta G, Taylor CW, Akinaga S, Whitesell L 2001 Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin Cancer Res 7:2076-2084
23. Laios I, Journe F, Laurent G, Nonclercq D, Toillon RA, Seo HS, Leclercq G 2003 Mechanisms governing the accumulation of estrogen receptor α in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens. J Steroid Biochem Mol Biol 87:207-221
24. 2+/calmodulin. J Biol Chem 180:13097-13104
25. Garcia Pedrero JM, del Rio B, Martinez-Campa C, Muramatsu M, Lazo PS, Ramos S 2002 Calmodulin is a selective modulator of estrogen receptors. Mol Endocrinol 16:947-960
26. Cui Y, Zhang M, Pestell R, Curran EM, Welshons WV, Fuqua SA 2004 Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity. Cancer Res 64:9199-9208
27. Fuqua SA, Wiltschke C, Zhang QX, Borg A, Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S, O'Connell P, Allred DC 2000 A hypersensitive estrogen receptor-α mutation in premalignant breast lesions. Cancer Res 60:4026-4029
28. Eakin CM, Maccoss MJ, Finney GL, Klevit RE 2007 Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase. Proc Natl Acad Sci USA 104:5794-5799
29. Whitesell L, Lindquist SL 2005 HSP90 and the chaperoning of cancer. Nat Rev Cancer 5:761-772
30. Hutchison KA, Dittmar KD, Pratt WB 1994 All of the factors required for assembly of the glucocorticoid receptor into a functional heterocomplex with heat shock protein 90 are preassociated in a self-sufficient protein folding structure, a "foldosome." J Biol Chem 269:27894-27899
31. Schlatter LK, Howard KJ, Parker MG, Distelhorst CW 1992 Comparison of the 90-kilodalton heat shock protein interaction with in vitro translated glucocorticoid and estrogen receptors. Mol Endocrinol 6:132-140
32. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18:306-360
33. Oxelmark E, Knoblauch R, Arnal S, Su LF, Schapira M, Garabedian MJ 2003 Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. J Biol Chem 278:36547-36555
34. Luders J, Demand J, Hohfeld J 2000 The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem 275:4613-4617
35. Alberti S, Esser C, Hohfeld J 2003 BAG-1: a nucleotide exchange factor of Hsc70 with multiple cellular functions. Cell Stress Chaperones 8:225-231
36. Freeman BC, Felts SJ, Toft DO, Yamamoto KR 2000 The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev 14:422-434
37. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, Patterson C 2001 The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3:93-96
38. Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV 2001 Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res 61:5771-5777
39. Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS 1984 Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology 114:629-637
40. Nardulli AM, Katzenellenbogen BS 1986 Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo. Endocrinology 119:2038-2046
41. Pakdel F, Le Goff P, Katzenellenbogen BS 1993 An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity. J Steroid Biochem Mol Biol 46:663-672
42. Monsma FJ, Jr., Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA 1984 Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. Endocrinology 115:143-153
43. Scheibel T, Buchner J 1998 The Hsp90 complex: a super-chaperone machine as a novel drug target. Biochem Pharmacol 56:675-682
44. Schulte TW, Akinaga S, Murakata T, Agatsuma T, Sugimoto S, Nakano H, Lee YS, Simen BB, Argon Y, Felts S, Toft DO, Neckers LM, Sharma SV 1999 Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones. Mol Endocrinol 13:1435-1448
45. Piper PW 2001 The Hsp90 chaperone as a promising drug target. Curr Opin Investig Drugs 2:1606-1610
46. Neckers L 2002 Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8:S55-S61
47. Bohen SP 1998 Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins. Mol Cell Biol 18:3330-3339
48. Whitesell L, Cook P 1996 Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol 10:705-712
49. Fan M, Bigsby RM, Nephew KP 2003 The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ERα) and essential for the antiproliferative activity of ICI 182,780 in ERα-positive breast cancer cells. Mol Endocrinol 17:356-365
50. Nirmala PB, Thampan RV 1995 Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 213:24-31
51. Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP 1999 Comparative analyses of mechanistic differences among antiestrogens. Endocrinology 140:5828-5840
52. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
53. Ylikomi T, Bocquel MT, Berry M, Gronemeyer H, Chambon P 1992 Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J 11:3681-3694
54. Knoblauch R, Garabedian MJ 1999 Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol 19:3748-3759
55. Komagata S, Nakajima M, Tsuchiya Y, Katoh M, Kizu R, Kyo S, Yokoi T 2006 Decreased responsiveness of naturally occurring mutants of human estrogen receptor α to estrogens and antiestrogens. J Steroid Biochem Mol Biol 100:79-86
56. Fan M, Rickert EL, Chen L, Aftab SA, Nephew KP, Weatherman RV 2007 Characterization of molecular and structural determinants of selective estrogen receptor downregulators. Breast Cancer Res Treat 103:37-44
57. Dennis AP, Haq RU, Nawaz Z 2001 Importance of the regulation of nuclear receptor degradation. Front Biosci 6:D954-D959
58. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
59. Brive L, Takayama S, Briknarova K, Homma S, Ishida SK, Reed JC, Ely KR 2001 The carboxyl-terminal lobe of Hsc70 ATPase domain is sufficient for binding to BAG1. Biochem Biophys Res Commun 289:1099-1105
60. Demand J, Alberti S, Patterson C, Hohfeld J 2001 Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr Biol 11:1569-1577
61. Ricketson D, Hostick U, Fang L, Yamamoto KR, Darimont BD 2007 A conformational switch in the ligandbinding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J Mol Biol 368:729-741
62. Fang L, Ricketson D, Getubig L, Darimont B 2006 Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain. Proc Natl Acad Sci USA 103:18487-18492
63. Herynk MH, Fuqua SA 2004 Estrogen receptor mutations in human disease. Endocr Rev 25:869-898
64. Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SA, Lopez GN, Kushner PJ, Pestell RG 2001 Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem 276:18375-18383
65. Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L 2005 Sumoylation of the estrogen receptor α hinge region regulates its transcriptional activity. Mol Endocrinol 19:2671-2684
66. Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL 2006 Acetylation of estrogen receptor α by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol Endocrinol 20:1479-1493